Biguanides in the treatment of obesity
Giulietti, M.
La Clinica Terapeutica 84(1): 99-100
1978
ISSN/ISBN: 0009-9074 PMID: 415837 Document Number: 130227
Document emailed within 1 workday
Related Documents
Tikhonova, E.P.; Kopelovich, M.A.; Grinchenko, T.S.; Beliaeva, G.A.; Chetvertakova, Z.T. 1975: Treatment of diabetes mellitus with biguanides Vrachebnoe Delo 9: 73-76Walter-Sack, I.; Wolfram, G.; Zöllner, N. 1979: Treatment of diabetes without biguanides. Observation on the course after changing treatment Münchener Medizinische Wochenschrift 121(35): 1109-1112
Vambera, M.; Cízková, M.; Petr, P. 1990: Lactic acidosis as a complication of treatment with biguanides Casopis Lekaru Ceskych 129(18): 562-566
Fövényi, J. 1971: Biguanides. Mode of action and role in the up-to-date treatment of diabetes mellitus Therapia Hungarica 19(2): 43-48
Schönleben, K.; Bünte, H. 1976: Interventions in obesity. Small intestine bypass surgery in the treatment of extreme obesity Therapie der Gegenwart 115(9): 1468-1498
Kroustrup, J.P.; Larsen, J.F. 2001: Treatment of morbid obesity with laparoscopic, adjustable gastric banding. Results after two years of experiences with a new surgical method for severe obesity Ugeskrift for Laeger 163(7): 918-921
Takahashi, T.; Odawara, M. 2011: Biguanides Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 1): 632-635
Safadi, R.; Yossepowitch, O.; Ben-Yehuda, A. 1996: Lactic acidosis associated with biguanides Harefuah 130(4): 280-283
Lavieuville, M.; Isnard, F. 1978: Focus on antidiabetic biguanides Journees Annuelles de Diabetologie de l'Hotel-Dieu 1978: 341-346
Uvnäs, B. 1973: Biguanides and lactic acid acidosis Lakartidningen 70(40): 3505
Bolzano, K. 1978: Biguanides: reasons for withdrawal of drugs and remaining indications Acta Medica Austriaca 5(3): 85-88
Hemmingsson, E.; Rössner, S. 2004: Physical activity in the treatment of obesity. Obesity--a chronic disease requiring life-long physical activity Lakartidningen 101(20): 1790-1797
Fövényi, J. 1970: Mechanism of action of biguanides and their place in the modern therapy of diabetes mellitus Orvosi Hetilap 111(26): 1503-1507
Sailer, D.; Ganawal, S.; Berg, G. 1979: Serum concentration of lactate in diabetic patients treated with biguanides in relationship to renal function Medizinische Klinik 74(9): 318-324
Seshiah, V.; Shanker, R.; Madhavan, R.; Venkataraman, S.; Sundaram, A.; Seshasaianam, C.; Sankaran, J.R. 1992: Effect of bed time intermediate acting insulin in NIDDM subjects refractory to a combination of sulphonylureas and biguanides Journal of the Association of Physicians of India 40(10): 666-668
Frey, H. 1972: An investigation of the effect of biguanides on glucose tolerance and body weight in overweight individuals without diabetes mellitus Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 92(15): 1036-1038
Calafiore, R.; Pietropaolo, M.; Basta, G.; Calcinaro, F. 1985: Biguanides and glucidic homeostasis: effects of metformin and phenformin on the intermediate metabolism and insulin receptors of normal subjects Recenti Progressi in Medicina 76(3): 152-153
Koch, U.; Gromus, B.; Bengel, J. 1986: Interdisciplinary group therapy as a possibility in the treatment of severe obesity--treatment concept and results Psychotherapie Psychosomatik Medizinische Psychologie 36(1): 32-46
Volfin, P.; Lescure, B. 1972: Divalent cation interaction in the regulation of gluconeogenesis enzymes in cellular and acellular kidney cortex systems: new data on mechanism of action of biguanides Israel Journal of Medical Sciences 8(6): 853
Kiernan, M.; Winkleby, M.A. 2000: Identifying patients for weight-loss treatment: an empirical evaluation of the NHLBI obesity education initiative expert panel treatment recommendations Archives of Internal Medicine 160(14): 2169-2176